PETMED EXPRESS, INC. (PETS) Free cash flow
- Free cash flow · 12 months (USD): Value $-27.77M; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value -16.45%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $-27.77M | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. $-23.81M − $3.96M ≈ $-27.77M |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | -16.45% | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. $-27.77M ÷ $168.86M × 100 ≈ -16.45% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $-23.81M | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | 0.81× | Operating cash flow / net income. Period ending 2026-06-30. $-23.81M ÷ $-29.28M ≈ 0.81× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | -23.81M USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations |
| Capital spending | 3.96M USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | -27.77M USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 168.86M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | -29.28M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $-27.77M | (m) | $-23.81M | $3.96M | (m) | $168.86M | (m) | $-29.28M | (m) | (m) | -16.45% | 0.81× |
| 2026-03-31 | $-33.01M | (m) | $-28.39M | $4.62M | (m) | $179.02M | (m) | $-57.29M | (m) | (m) | -18.44% | 0.50× |
| 2025-12-31 | $-22.92M | (m) | $-16.64M | $6.28M | (m) | $186.96M | (m) | $-64.87M | (m) | (m) | -12.26% | 0.26× |
| 2025-09-30 | $-15.68M | (m) | $-8.60M | $7.08M | (m) | $198.26M | (m) | $-55.02M | (m) | (m) | -7.91% | 0.16× |
| 2025-06-30 | $-4.76M | (m) | $964.00K | $5.72M | (m) | $211.94M | (m) | $-44.18M | (m) | (m) | -2.24% | -0.02× |
| 2025-03-31 | $-395.00K | (m) | $4.72M | $5.11M | (m) | $226.97M | (m) | $-6.27M | (m) | (m) | -0.17% | -0.75× |
| 2024-12-31 | $855.00K | (m) | $4.83M | $3.98M | (m) | (m) | (m) | $357.00K | (m) | (m) | (m) | 13.53× |
| 2024-09-30 | $-918.00K | (m) | $3.40M | $4.32M | (m) | (m) | (m) | $-963.00K | (m) | (m) | (m) | -3.53× |
| 2024-06-30 | $-8.80M | (m) | $-4.76M | $4.04M | (m) | (m) | (m) | $-2.57M | (m) | (m) | (m) | 1.85× |
| 2024-03-31 | $-194.00K | (m) | $4.32M | $4.51M | (m) | (m) | (m) | $-7.46M | (m) | (m) | (m) | -0.58× |
| 2023-12-31 | $1.73M | (m) | $6.92M | $5.19M | (m) | (m) | (m) | $-2.66M | (m) | (m) | (m) | -2.60× |
| 2023-09-30 | $17.42M | (m) | $22.48M | $5.06M | (m) | (m) | (m) | $-6.08M | (m) | (m) | (m) | -3.70× |
| 2023-06-30 | $16.55M | (m) | $21.98M | $5.43M | (m) | (m) | (m) | $-3.43M | (m) | (m) | (m) | -6.41× |
| 2023-03-31 | $22.54M | (m) | $27.80M | $5.26M | (m) | (m) | (m) | $233.00K | (m) | (m) | (m) | 119.33× |
| 2022-12-31 | $22.98M | (m) | $26.80M | $3.81M | (m) | (m) | (m) | $11.40M | (m) | (m) | (m) | 2.35× |
| 2022-09-30 | $19.41M | (m) | $22.53M | $3.12M | (m) | (m) | (m) | $15.68M | (m) | (m) | (m) | 1.44× |
| 2022-06-30 | $23.04M | (m) | $25.30M | $2.26M | (m) | (m) | (m) | $19.45M | (m) | (m) | (m) | 1.30× |
| 2022-03-31 | $16.75M | (m) | $18.50M | $1.75M | (m) | (m) | (m) | $21.10M | (m) | (m) | (m) | 0.88× |
| 2021-12-31 | $26.38M | (m) | $28.23M | $1.85M | (m) | (m) | (m) | $21.85M | (m) | (m) | (m) | 1.29× |
| 2021-09-30 | $23.75M | (m) | $25.96M | $2.21M | (m) | (m) | (m) | $25.20M | (m) | (m) | (m) | 1.03× |
| 2021-06-30 | $48.09M | (m) | $50.85M | $2.76M | (m) | (m) | (m) | $27.26M | (m) | (m) | (m) | 1.87× |
| 2021-03-31 | $37.64M | (m) | $40.08M | $2.43M | (m) | (m) | (m) | $30.60M | (m) | (m) | (m) | 1.31× |
| 2020-12-31 | $36.56M | (m) | $38.89M | $2.33M | (m) | (m) | (m) | $30.79M | (m) | (m) | (m) | 1.26× |
| 2020-09-30 | $33.65M | (m) | $36.74M | $3.09M | (m) | (m) | (m) | $30.02M | (m) | (m) | (m) | 1.22× |
| 2020-06-30 | $25.34M | (m) | $27.61M | $2.26M | (m) | (m) | (m) | $28.28M | (m) | (m) | (m) | 0.98× |
| 2020-03-31 | $36.53M | (m) | $38.84M | $2.31M | (m) | $284.13M | (m) | $25.85M | (m) | (m) | 12.86% | 1.50× |
| 2019-12-31 | $32.75M | (m) | $34.69M | $1.94M | (m) | (m) | (m) | $25.47M | (m) | (m) | (m) | 1.36× |
| 2019-09-30 | $41.44M | (m) | $42.03M | $586.00K | (m) | (m) | (m) | $26.41M | (m) | (m) | (m) | 1.59× |
| 2019-06-30 | $22.63M | (m) | $23.14M | $506.00K | (m) | (m) | (m) | $30.50M | (m) | (m) | (m) | 0.76× |
| 2019-03-31 | $44.52M | (m) | $45.14M | $620.00K | (m) | $283.42M | (m) | $37.74M | (m) | (m) | 15.71% | 1.20× |
| 2018-12-31 | $33.61M | (m) | $34.26M | $646.00K | (m) | (m) | (m) | $41.30M | (m) | (m) | (m) | 0.83× |
| 2018-09-30 | $38.67M | (m) | $39.48M | $803.00K | (m) | (m) | (m) | $42.58M | (m) | (m) | (m) | 0.93× |
| 2018-06-30 | $44.55M | (m) | $45.52M | $966.00K | (m) | (m) | (m) | $40.59M | (m) | (m) | (m) | 1.12× |
| 2018-03-31 | $36.68M | (m) | $37.38M | $703.00K | (m) | $273.80M | (m) | $37.28M | (m) | (m) | 13.40% | 1.00× |
| 2017-12-31 | $49.40M | (m) | $50.71M | $1.31M | (m) | (m) | (m) | $34.60M | (m) | (m) | (m) | 1.47× |
| 2017-09-30 | $32.63M | (m) | $37.72M | $5.09M | (m) | (m) | (m) | $30.36M | (m) | (m) | (m) | 1.24× |
| 2017-06-30 | $39.95M | (m) | $47.99M | $8.04M | (m) | (m) | (m) | $26.50M | (m) | (m) | (m) | 1.81× |
| 2017-03-31 | $36.60M | (m) | $47.20M | $10.60M | (m) | (m) | (m) | $23.82M | (m) | (m) | (m) | 1.98× |
| 2016-12-31 | $247.00K | (m) | $30.06M | $29.81M | (m) | (m) | (m) | $21.73M | (m) | (m) | (m) | 1.38× |
| 2016-09-30 | $8.98M | (m) | $34.80M | $25.81M | (m) | (m) | (m) | $21.80M | (m) | (m) | (m) | 1.60× |
| 2016-06-30 | $724.00K | (m) | $23.35M | $22.62M | (m) | (m) | (m) | $21.40M | (m) | (m) | (m) | 1.09× |
| 2016-03-31 | $923.00K | (m) | $21.05M | $20.13M | (m) | (m) | (m) | $20.57M | (m) | (m) | (m) | 1.02× |
| 2015-12-31 | $24.45M | (m) | $25.15M | $697.00K | (m) | (m) | (m) | $20.10M | (m) | (m) | (m) | 1.25× |
| 2015-09-30 | $21.77M | (m) | $22.49M | $721.00K | (m) | (m) | (m) | $20.01M | (m) | (m) | (m) | 1.12× |
| 2015-06-30 | $27.57M | (m) | $28.60M | $1.02M | (m) | (m) | (m) | $18.24M | (m) | (m) | (m) | 1.57× |
| 2015-03-31 | $31.13M | (m) | $32.04M | $918.00K | (m) | (m) | (m) | $17.45M | (m) | (m) | (m) | 1.84× |
| 2014-12-31 | $24.96M | (m) | $25.36M | $404.00K | (m) | (m) | (m) | $17.03M | (m) | (m) | (m) | 1.49× |
| 2014-09-30 | $12.35M | (m) | $12.74M | $386.00K | (m) | (m) | (m) | $16.77M | (m) | (m) | (m) | 0.76× |
| 2014-06-30 | $7.87M | (m) | $7.92M | $47.00K | (m) | (m) | (m) | $18.19M | (m) | (m) | (m) | 0.44× |
| 2014-03-31 | $13.46M | (m) | $13.51M | $45.00K | (m) | (m) | (m) | $17.97M | (m) | (m) | (m) | 0.75× |
| 2013-12-31 | $8.99M | (m) | $9.12M | $136.00K | (m) | (m) | (m) | $18.05M | (m) | (m) | (m) | 0.51× |
| 2013-09-30 | $21.55M | (m) | $21.91M | $366.00K | (m) | (m) | (m) | $18.08M | (m) | (m) | (m) | 1.21× |
| 2013-06-30 | $18.91M | (m) | $19.33M | $423.00K | (m) | (m) | (m) | $17.97M | (m) | (m) | (m) | 1.08× |
| 2013-03-31 | $12.66M | (m) | $13.29M | $626.00K | (m) | (m) | (m) | $17.16M | (m) | (m) | (m) | 0.77× |
| 2012-12-31 | $27.90M | (m) | $28.51M | $610.00K | (m) | (m) | (m) | $16.56M | (m) | (m) | (m) | 1.72× |
| 2012-09-30 | $19.23M | (m) | $19.93M | $703.00K | (m) | (m) | (m) | $15.88M | (m) | (m) | (m) | 1.26× |
| 2012-06-30 | $24.82M | (m) | $25.65M | $830.00K | (m) | (m) | (m) | $15.77M | (m) | (m) | (m) | 1.63× |
| 2012-03-31 | $19.69M | (m) | $20.39M | $705.00K | (m) | (m) | (m) | $16.66M | (m) | (m) | (m) | 1.22× |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | $29.44M | (m) | $30.11M | $667.00K | (m) | (m) | (m) | $20.87M | (m) | (m) | (m) | 1.44× |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | $26.64M | (m) | $27.68M | $1.05M | (m) | (m) | (m) | $26.00M | (m) | (m) | (m) | 1.06× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS HEALTH Corp (CVS) | United States | $108.783B | 27.06 |